Friday, August 31, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
SMS service in offing for public awareness on cheaper drugs
Economic Times
In reply to a question, Azad said the Department of Pharmaceuticals has prepared a draft Uniform Code of Pharmaceutical Marketing Practices (UCPMP) to be adopted voluntarily following reports of some pharma companies making promotional expenses to ...
See all stories on this topic »
Janssen Pharmaceuticals, Inc. announces RISPERDAL® consumer protection ...
Sacramento Bee
TITUSVILLE, N.J., Aug. 30, 2012 -- /PRNewswire/ -- Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, announced a settlement and consent decree today with 36 states and the District of Columbia regarding previously disclosed allegations ...
See all stories on this topic »
3 Pharmaceutical Stocks to Sell Now
Investorplace.com
The overall ratings of three Pharmaceutical stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Medicis Pharmaceutica (NYSE:MRX) ratings are on the decline this week as the company earns an ...
See all stories on this topic »
Pharmaceuticals for Beginners 2012 - Fullermoney
Proactive Investors UK
Pharmaceuticals for Beginners 2012 Thanks to a subscriber for this highly educative 329-page report for anyone with an interest in the pharmaceuticals sector. The full report is posted in the Subscriber's Area but here is a section on diabetes ...
See all stories on this topic »
Catalyst Pharmaceutical closes $6M stock offering
Bizjournals.com (blog)
Catalyst Pharmaceutical Partners has announced the closing of its second stock offering of the year. The offering, which was announced Tuesday, was for 4 million shares of the company's common stock and warrants to purchase an additional 1.2 million ...
See all stories on this topic »
Sihuan Pharmaceutical Announces 2012 Interim Results
The Herald | HeraldOnline.com
30, 2012 — /PRNewswire-Asia/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Company"), a leading pharmaceutical company with the largest cardio-cerebral vascular drug franchise in China's prescription drug ...
See all stories on this topic »
Orchid sheds a good asset to cut debt
Livemint
Would Orchid Chemicals and Pharmaceuticals Ltd have sold a good slice of its active pharmaceutical ingredients (API) business if it was not weighed down by debt? Perhaps not, and that may explain why investors do not appear thrilled by the transaction, ...
See all stories on this topic »
Cynthia's murder: Pharmaceutical group petitions prosecutor over member's trial
CHANNELS
The Pharmaceutical Society of Nigeria, (PSN), has petitioned the Director of Public Prosecution, DPP, to properly review the murder case of Cynthia Osogoku to ensure that pharmacists were not persecuted wrongly. The four suspects accused of killing ...
See all stories on this topic »

CHANNELS
IsZo Capital & Black Horse Write to Taro Pharmaceutical Demanding Information ...
The Herald | HeraldOnline.com
31, 2012 — /PRNewswire/ -- IsZo Capital Management LP and Black Horse Capital Advisors LLC, two of the largest minority shareholders of Taro Pharmaceutical Industries Ltd. (NYSE: TARO), announced today that they delivered the following letter to Taro ...
See all stories on this topic »
Ironwood drug's a go
Boston Herald
"This is a major milestone in the development of a young pharmaceutical company, with the potential for significant revenue," said Gregory Wade, managing director of Health Care Equity Research, although he projected that the company would not turn a ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

Thursday, August 30, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
FDA approves Teva Pharmaceutical's version of Amgen's Neupogen
Economic Times
... expensive, than duplicating conventional chemical-based compounds. Generic drugmakers like Israel-based Teva are pushing into the field of biosimilars as global pharmaceutical companies face the loss of patent protection on many established drugs.
See all stories on this topic »
Hospira deal to be Rs 7-8 EPS accretive: Orchid Chemicals
Moneycontrol.com
Hospira deal to be Rs 7-8 EPS accretive: Orchid Chemicals. Shares of Orchid Chemicals were on the rise after the pharmaceutical company sold its penicillin and penem business to US-based Hospira Inc for USD 200 million. Source: CNBC-TV18 ...
See all stories on this topic »
Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into ...
Economic Times
MUMBAI: In yet another instance of India Inc occupying a larger seat in the global league tables, three out of the top 10 fastest-growing generic companies globally are now from India . Besides being an indication of the acceptance of domestic ...
See all stories on this topic »
"We took an incorrect decision by targeting the wrong market"
Hindu Business Line
Our research services and methodologies complement our software solutions and enable us to help strengthen the information and analytics needed by pharmaceutical and biotech companies. We use Microsoft, Java and other technologies with service ...
See all stories on this topic »

Hindu Business Line
Pharmaceutical firm Teva API to set up unit in Indore SEZ; to invest 1000 crore
Economic Times
INDORE: Pharmaceutical firm Teva API India plans to invest about Rs 1,000 crore over the next five years in setting up of a formulation unit in the Indore special economic zone (SEZ), an official said today. "Teva API is planning to invest about Rs 1 ...
See all stories on this topic »
Clearance of Michigan facility by FDA marginally positive for Sun Pharma: Nomura
Myiris.com
Sun Pharmaceutical Industries, one of the leading durg makers in India, announced on August 28 that the USFDA has allowed its arm Caraco to resume operations at its manufacturing facility and packaging sites in Detriot and Wixom, Michigan following an ...
See all stories on this topic »
BioSante Pharmaceuticals, Inc. to Present at Stifel Nicolaus Healthcare ...
4-traders
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Stephen M. Simes, BioSante's president & CEO, will present a corporate update at the Stifel Nicolaus Healthcare Conference and Rodman & Renshaw Global Investment Conferences.
See all stories on this topic »
People on the move: outsourcing jobs
OutSourcing-Pharma.com
Mark Hanley, CEO said: "Now more than ever pharmaceutical companies and contract research organisations (CROs) want to conduct clinical trials that are cost-effective, efficient, and maintain the highest standards for patient safety. "Joanne brings a ...
See all stories on this topic »

OutSourcing-Pharma.com
Astex Pharmaceuticals to Present at September Investor Conferences
Equities.com
30, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that members of its senior management team will ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Wednesday, August 29, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Hospira to buy Orchid's API mfg, R&D units in $200 mn deal
Zee News
New Delhi: Orchid Chemicals & Pharmaceuticals on Wednesday said it will sell various assets including active pharmaceutical ingredients (API) business and a R&D facility to the US-based Hospira Inc for USD 200 million (nearly Rs 1,112 crore).
See all stories on this topic »

Zee News
Manipal varsity to offer Masters in Pharmaceutical Medicine
Hindu Business Line
A press release by the university said here that Hibernia College, Dublin – in collaboration with Manipal College of Pharmaceutical Sciences, Manipal University – will offer a programme in Master of Sciences in Pharmaceutical Medicine from October.
See all stories on this topic »
People on the move: jobs in pharma
In-PharmaTechnologist.com
In a statement, he said: "No one is blind to the challenges that confront the pharmaceutical sector and this company, but the underlying strengths of AstraZeneca in delivering on its strategy are clear." Commentators are positive the move will be good ...
See all stories on this topic »

In-PharmaTechnologist.com
Pharmaceutical sales rep access reducing most among oncologists in USA
The Pharma Letter
As more pharmaceutical companies prepare to bring new oncology drugs to market, their sales representatives face a rising hurdle – oncologists in the USA are reducing the number of times they will see them. According to the spring 2012 AccessMonitor, ...
See all stories on this topic »
New method simplifies pharmaceutical production of proteins
News-Medical.net
Engineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular ...
See all stories on this topic »
Lower Macungie Township to be new home for pharmaceutical packaging ...
Lehighvalleylive.com
A pharmaceutical packaging company will move from New Jersey to Lower Macungie Township, creating more than 280 jobs in the Lehigh Valley, Pennsylvania Gov. Tom Corbett said today. The company, Quality Packaging Specialists International, will ...
See all stories on this topic »
4 Low-Debt Pharmaceutical Stocks Backed By Analysts
Seeking Alpha
With this in mind, we looked for stocks in the pharmaceutical category where debt has been kept to a minimum. The companies that made our cut have also been recently reviewed by analysts and given "Buy" or "Strong Buy" ratings. See the list below to ...
See all stories on this topic »
Healthcare Review: Discovery Laboratories & Rexahn Pharmaceuticals Jump ...
Reuters
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) stock plummeted 20.90% to $1.50 after the company said it has entered into definitive agreements to sell 4.0 million shares of the Company's common stock, and common stock purchase warrants to ...
See all stories on this topic »
Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of ...
Sacramento Bee
28, 2012 -- /PRNewswire/ -- Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Tuesday, August 28, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Sun Pharma's Caraco gets USFDA nod to resume drug production
Economic Times
NEW DELHI: Sun Pharmaceutical Industries today said American health regulator has approved resumption of manufacturing operations at its US-based subsidiary, Caraco for two drugs after inspections of facilities early this year. Subsequent to ...
See all stories on this topic »
Special Report: China's "wild east" drug store
Reuters
SHANGHAI/LONDON (Reuters) - Philippe Andre, a detective in the murky world of Chinese pharmaceuticals, has some alarming tales to tell. In May last year, he visited a factory an hour outside Shanghai that supposedly produced a pharmaceutical ...
See all stories on this topic »
Catalyst Pharmaceutical Partners, Inc. Raises $6 Million in Registered Direct ...
Equities.com
28, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has entered into definitive agreements to sell (i) 4.0 million shares of the Company's common stock, and (ii) common stock purchase warrants to ...
See all stories on this topic »
5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year
Seeking Alpha
5 Pharmaceutical Companies With EMA Or MHRA Catalysts This Year. August 28, 2012 by: Markus Aarnio | includes: ALXA, GENT, HZNP, SCMP, SVNT. Pharmaceutical companies very often have a run-up leading into drug approval dates. I usually try to buy ...
See all stories on this topic »
Reckitt climbs as analysts say its pharma business could be worth up to £5bn ...
The Guardian (blog)
Reckitt Benckiser's pharmaceutical business could be worth up to £5bn if it were sold off, according to analysts at Morgan Stanley, despite competition worries surrounding its suboxone heroin substitute. The company, best known for its Cillit Bang and ...
See all stories on this topic »
Cipla plans to shift headquarters, keen on buying Rs 270 crore space in ...
Economic Times
MUMBAI: Pharmaceutical major Cipla is close to buying office space in central Mumbai, in a deal worth over Rs 270 crore, three people familiar with the development said. The office space under consideration - about 1.30 lakh sq ft at Peninsula Business ...
See all stories on this topic »
REXAHN PHARMACEUTICALS, INC. : Rexahn Pharmaceuticals Announces ...
4-traders
Rockville, MD, August 28, 2012 - Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II ...
See all stories on this topic »
Watson Pharmaceuticals Is A Buy
Seeking Alpha
Watson Pharmaceuticals Inc. (WPI) is one of my 10/10/10 stocks. My philosophy is that the only way to have a portfolio that will return in excess of 10% is to only buy stocks that are projected to have a 10% increase in Revenue, Earnings and Total Return.
See all stories on this topic »
The Pharmaceutical Market: China
The Herald | HeraldOnline.com
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The ...
See all stories on this topic »
Pascal Soriot Appointed Chief Executive Officer of AstraZeneca
Pharmaceutical Processing
A French national, 53 year old Pascal Soriot joins AstraZeneca from Roche AG where he has served as Chief Operating Officer of the company's pharmaceuticals division since 2010. In his current role he has global responsibility for development, ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Monday, August 27, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
West Pharma Packaging starts moulding unit in Sri City
Hindu Business Line
West Pharmaceutical India Packaging Private Ltd, a subsidiary of West Pharmaceutical Services Inc, US, kicked off construction of its compression moulding facility in Sri City, near Chennai. The plant will become part of the company's global supply ...
See all stories on this topic »

Hindu Business Line
Global pharmaceutical competitiveness
BusinessDay
Over the years, the nation's pharmaceutical industry has remained a weak competitor when compared with international firms, following its inability to manufacture drugs that meet international standards. This inability to compete in the global market ...
See all stories on this topic »

BusinessDay
NSF International First to Offer High Quality Secondary Reference Standards to ...
Moneylife
NSF International, an independent global public health and safety organization which develops standards, and tests and certifies products for the pharmaceutical, dietary supplement, food, water, and consumer products industries, is the first to offer ...
See all stories on this topic »
Cipher Pharmaceuticals to present at the Rodman & Renshaw 14th Annual ...
Stockhouse
Cipher Pharmaceuticals (TSX: DND; OTC: CPHMF) is a growing specialty pharmaceutical company that commercializes novel formulations of successful, currently marketed molecules. Cipher's strategy is to in-license clearly differentiated products, advance ...
See all stories on this topic »
Tonix Pharmaceuticals' CEO Highlights Connection Between Disturbed Sleep ...
Equities.com
NEW YORK, NY -- (Marketwire) -- 08/27/12 -- Tonix Pharmaceuticals Holding Corp. (OTCQB: TNXP) (PINKSHEETS: TNXP) ("TONIX" or the "Company"), a specialty pharmaceutical company developing non-addictive treatments for the chronic pain syndrome, ...
See all stories on this topic »
WATSON PHARMACEUTICALS, INC. : Watson to Present at the Morgan Stanley ...
4-traders
27, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Siggi Olafsson, Watson's President, Global Generics, will provide an overview and update of the Company's business at ...
See all stories on this topic »
Idenix falls as FDA halts testing of 2nd drug
Pharmaceutical Processing
Loading... Idenix Pharmaceuticals Inc. shares fell Monday after the company said the Food and Drug Administration is halting development of another one of its hepatitis C drugs. Idenix said the FDA is barring it from testing a drug called IDX19368 on ...
See all stories on this topic »
Bosch meets pharmaceutical demand for flexibility
Packaging Europe
The new design offers improved ergonomics and accessibility. Meeting the growing needs in today's pharmaceutical industry for flexibility, the unit can be used in the lab for extremely small batches. Parameters required in future production operations ...
See all stories on this topic »

Packaging Europe
Threat to privacy in e-Health records
Herald Sun
PATIENTS who want to keep private a visit to a psychiatrist, the use of a mental health medicine or an abortion under the new e-Health online system will have to ensure Medicare and pharmaceutical subsidy data is not linked to the new record. The only ...
See all stories on this topic »


Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Sunday, August 26, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Iran sees gaining $400m in pharmaceutical exports
Tehran Times
TEHRAN - Iran plans to export as much as 5 trillion rials (some $400 million) worth of pharmaceutical products in the current calendar year, which ends on March 20, 2013, the health minister said. Marzieh Vahid-Dastjerdi told the IRNA News Agency that ...
See all stories on this topic »
Fire at Panelav unit of Alembic Pharma
Business Standard
A major fire broke out at a pharmaceutical plant at Panelav near here, officials said. The fire, which broke out at a unit of Alembic Pharmaceuticals last night, was brought under control this morning after five hours, they said. "A fire broke out at ...
See all stories on this topic »
UK Pharmaceutical Industry Lead Stephen Whitehead Joins Global Summit
The Holmes Report
Whitehead, a veteran communications professional who became head of the UK's pharmaceutical industry trade association in June of last year, will be part of a panel of senior public relations professionals discussing "Communicating Through Controversy: ...
See all stories on this topic »

The Holmes Report
Hikma leads a surge in pharmaceutical stocks
This is Money
Sales of injectable medication at Hikma Pharmaceuticals have increased by almost 100 per cent in value. Hikma, which is based in the Jordanian capital Amman, listed in London in 2005 and is part of the FTSE 250. In the six months to June turnover was ...
See all stories on this topic »

This is Money
Greek Pharmacists to End Prescriptions on Credit
Bloomberg
The Pan-Hellenic Pharmaceutical Association, which represents Greece's 12,000 pharmacies, said its members will no longer supply drugs prescribed by the country's National Organization for Health Care Provision without immediate payment in cash ...
See all stories on this topic »
The Week in Review: Joincare To Invest $157 Million For Antibiotic Facility
Seeking Alpha
Joincare Pharmaceutical Group (SHA: 600380) announced its Board has approved the investment of $157 million to increase the company's production of carbapenem antibiotics. The project will be located in Fuping New Area, Shenzhen. Joincare is based ...
See all stories on this topic »
Simulations Plus signs collaboration agreement with pharmaceutical company
Equities.com
Aug 25, 2012 (Datamonitor via COMTEX) -- Simulations Plus, Inc., a provider of simulation and modeling software for pharmaceutical discovery and development, has signed a collaboration agreement with a pharmaceutical company to add a transdermal ...
See all stories on this topic »
Transcept names new vice president and CFO
Equities.com
Aug 26, 2012 (Datamonitor via COMTEX) -- Transcept Pharmaceuticals, Inc., a specialty pharmaceutical company, has announced that Leone Patterson will serve as the company's vice president and CFO. Ms Patterson will have primary responsibility for all ...
See all stories on this topic »
Merck to pursue approval for vorapaxar in prior MI patients
TheHeart.Org
Before that she was science editor at Scrip World Pharmaceutical News, where she had worked since 1989. Sue studied pharmacy at Manchester University, UK and worked as an NHS hospital pharmacist for a couple of years before switching to medical ...
See all stories on this topic »
AmDerma and Oculus sign agreement to develop dermatological compounds
Equities.com
Aug 26, 2012 (Datamonitor via COMTEX) -- AmDerma Pharmaceuticals, LLC, a developer of pharmaceutical products with dermatological indications, and Oculus Innovative Sciences, a healthcare company, have announced the execution of an agreement to ...
See all stories on this topic »


Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Saturday, August 25, 2012

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news
 
Millennium Pharmaceuticals Cambridge expansion tests triggers backlash at ...
Boston.com
That opposition has already scored one major victory: stalling a proposed 246,000-square-foot office and lab complex near Central Square that would house drug maker Millennium Pharmaceuticals. And now more development could be in question as ...
See all stories on this topic »
Guj pharma cos pip slowdown on FII pill
Daily News & Analysis
Defying the downturn trend on stock exchanges, pharmaceutical companies have once again proven to be defensive stocks. Share prices of six Gujarat-based pharmaceutical companies have not only touched their 52-week high in August, but have also ...
See all stories on this topic »
US FDA approves Watson Pharma's lidocaine topical patch 5%
pharmabiz.com
The United States Food and Drug Administration (FDA) has granted final approval to Watson Pharmaceuticals' Abbreviated New Drug Application (ANDA) for lidocaine topical patch five per cent, the generic equivalent to Endo's Lidoderm. Watson plans to ...
See all stories on this topic »
NPS Pharmaceuticals: A Strong Near-Term Catalyst
Seeking Alpha
NPS Pharmaceuticals (NPSP) is a biopharmaceutical company focused on bringing orphan products to patients with rare disorders and few, if any, therapeutic options. NPS is advancing two late-stage registration programs. A New Drug Application is ...
See all stories on this topic »
FIPB gives nod to eight pharma FDI proposals
Times of India
Organisation of Pharmaceutical Producers of India (OPPI), the lobby body of foreign pharma companies in India, has welcomed the move. "This is a one small step for encouraging FDI in India," said OPPI president Ranjit Shahani, adding that similar ...
See all stories on this topic »
Watson Pharmaceuticals Incorporated Stock Rating Reaffirmed by Leerink ...
Jags Report
Watson Pharmaceuticals Incorporated traded up 5.61% on Friday, hitting $83.04. Watson Pharmaceuticals Incorporated has a 1-year low of $55.00 and a 1-year high of $81.00. The company has a market cap of $10.600 billion and a price-to-earnings ratio of ...
See all stories on this topic »
Healthcare Review: Watson Pharmaceuticals, Pozen, Discovery Laboratories ...
Pharmaceutical Processing
Watson Pharmaceuticals, Inc. (NYSE:WPI) stock climbed 4.12% to $81.87 after the company announced that its subsidiary, Watson Laboratories, Inc., has received final approval from the United States Food and Drug Administration (FDA) on its Abbreviated ...
See all stories on this topic »
West Sets Up New Facility in India - Analyst Blog
NASDAQ
West Pharmaceutical Services' ( WST ) indirect subsidiary, West Pharmaceutical India Packaging Private Ltd., has commenced the construction of a new compression molding facility in Sri City, India. The facility will be a quantum of the company's global ...
See all stories on this topic »
Watson Stock Hits High On Generic Lidoderm Approval
Investor's Business Daily
Shares of Watson Pharmaceuticals (WPI) hit a new all-time high Friday after the company received FDA approval for a generic version of Lidoderm. Watson announced Thursday that it would begin selling the product, which delivers the painkiller lidocaine ...
See all stories on this topic »
Arena Is Poised To Move
Seeking Alpha
Investors in Arena Pharmaceuticals, Inc. (ARNA) got great news in late June that the company's obesity drug Belviq had received FDA approval. A combination of excitement and irrational exuberance then took over and sent Arena toward a 52-week high of ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost